193 / 204
Notes To The
Financial Statements
As at 31 March 2019
39. Explanation of transition to MFRS (cont’d.)
The effects of transitioning from FRS to MFRS, adoptions of MFRS 9 and MFRS 141 are as follows: (cont’d.)
Reconciliation of Statement of Comprehensive Income
For the year ended 31 March 2018 (cont’d.)
Previously
reported
under FRS
RM’000
Effects from
transition to
MFRS
RM’000
Effects from
adoption of
MFRS 9
RM’000
Effects from
adoption
of MFRS 141
RM’000
New carrying
amount
under MFRS
RM’000
Group (cont’d.)
Total comprehensive income
attributable to:
Equity holders of the
Company
27,527
-
(1,547)
(701)
25,279
Non-controlling interest
1,070
-
-
(178)
892
Total comprehensive income
for the year
28,597
-
(1,547)
(879)
26,171
Reconciliation of Statement of Cash Flows
For the year ended 31 March 2018
Previously
reported
under FRS
RM’000
Effects from
adoption of
MFRS 9
RM’000
Effects from
adoption of
MFRS 141
RM’000
Reported
under MFRS
RM’000
Group
Profit before tax
63,303
(1,547)
(791)
60,965
Depreciation for property, plant and equipment
9,484
-
1,451
10,935
Amortisation of biological assets
1,451
-
(1,451)
-
Fair value changes on biological assets
-
-
791
791
Allowance for impairment on trade receivables
9
1,547
-
1,556
Purchase of property, plant and equipment
(3,767)
-
(6,146)
(9,913)
Additions to biological assets
(6,146)
-
6,146
-
40. Authorisation of financial statements for issue
The financial statements for the year ended 31 March 2019 were authorised for issue in accordance with a
resolution of the directors on 24 June 2019.
financial
statements
189